MHRA’s new guidance on using real-world data to support clinical trials could get medicines to patients sooner
This new guidance follows consultation with stakeholders from the pharmaceutical industry, academic research, trade associations, patient organisations/charities, healthcare providers and regulatory organisations.
Read the news from Medicines and Healthcare products Regulatory Agency published on 16 December 2021.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (15 mars 2022). MHRA’s new guidance on using real-world data to support clinical trials could get medicines to patients sooner. ELSIBI. Consulté le 18 février 2025 à l’adresse https://doi.org/10.58079/o5w7